Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Klara Westman"'
Autor:
Claudia S. Cabrera, Alison S. Lee, Marita Olsson, Volker Schnecke, Klara Westman, Marcus Lind, Peter J. Greasley, Stanko Skrtic
Publikováno v:
Kidney International Reports, Vol 5, Iss 10, Pp 1651-1660 (2020)
Introduction: It remains unclear whether an increased progression rate of chronic kidney disease (CKD) adds predictive information regarding cardiovascular disease (CVD) risk. The aim of this study was to evaluate the association between CKD progress
Externí odkaz:
https://doaj.org/article/25cf5e66c41a48909bac599e2171e8cd
Autor:
Volker Schnecke, Peter J. Greasley, Alison S. Lee, Marcus Lind, Klara Westman, Marita Olsson, Stanko Skrtic, Claudia Cabrera
Publikováno v:
Kidney International Reports, Vol 5, Iss 10, Pp 1651-1660 (2020)
Kidney International Reports
Kidney International Reports
Introduction It remains unclear whether an increased progression rate of chronic kidney disease (CKD) adds predictive information regarding cardiovascular disease (CVD) risk. The aim of this study was to evaluate the association between CKD progressi
Autor:
Klara Westman, Henrik Imberg, Magnus O. Wijkman, Irl B. Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Marcus Lind
Publikováno v:
Journal of Diabetes and its Complications. 36:108110
In this post-hoc analysis of data from a randomised clinical trial, we compared the effect of liraglutide to placebo on markers of insulin secretion in persons with type 2 diabetes treated with multiple daily insulin injections. Liraglutide increased
Autor:
Shilan Seyed Ahmadi, Erik Schwarcz, William H. Polonsky, Klara Westman, Sofia Dahlqvist, Aldina Pivodic, Marcus Lind, Irl B. Hirsch, Tim Heise, Jarl Hellman, Magnus Wijkman, Arndís F. Ólafsdóttir, Magnus Ekelund
OBJECTIVE According to recent guidelines, individuals with type 1 diabetes should spend RESEARCH DESIGN AND METHODS In the GOLD randomized crossover trial, 161 individuals with type 1 diabetes treated with multiple daily insulin injections (MDI) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1b0f5e3bf783253e92be84536f6212
https://doi.org/10.2337/figshare.12357506.v2
https://doi.org/10.2337/figshare.12357506.v2
Autor:
Marcus Lind, Erik Schwarcz, Magnus Wijkman, William Polonsky, Tim Heise, Magnus Ekelund, Jarl Hellman, Irl B Hirsch, Sofia Dahlqvist, Arndís F Ólafsdóttir, Aldina Pivodic, Klara Westman, Shilan Seyed Ahmadi
Objective: According to recent guidelines, individuals with type 1 diabetes should spend less than 4.0% per day with glucose levels Research methods: In the GOLD randomised cross-over trial, 161 individuals with type 1 diabetes treated with multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7f911383ba1f0d1030238e9a322c821
https://doi.org/10.2337/figshare.12357506.v1
https://doi.org/10.2337/figshare.12357506.v1
Autor:
Klara Westman, Henrik Imberg, Sofia Dahlqvist, Jaakko Tuomilehto, Irl B. Hirsch, Marcus Lind, Henrik Albrektsson
Publikováno v:
Primary care diabetes. 15(3)
From the MDI-liraglutide study, we evaluated variables associated with endogenous insulin production in persons with multiple daily insulin injections-treated type 2 diabetes by relating C-peptide, proinsulin and proinsulin/C-peptide ratio at baselin
Autor:
Shilan, Seyed Ahmadi, Klara, Westman, Aldina, Pivodic, Arndís F, Ólafsdóttir, Sofia, Dahlqvist, Irl B, Hirsch, Jarl, Hellman, Magnus, Ekelund, Tim, Heise, William, Polonsky, Magnus, Wijkman, Erik, Schwarcz, Marcus, Lind
Publikováno v:
Diabetes Care
OBJECTIVE According to recent guidelines, individuals with type 1 diabetes should spend